| First Author | Sun Y | Year | 2017 |
| Journal | Biochim Biophys Acta | Volume | 1864 |
| Issue | 4 | Pages | 719-727 |
| PubMed ID | 28137643 | Mgi Jnum | J:251365 |
| Mgi Id | MGI:6105744 | Doi | 10.1016/j.bbamcr.2017.01.016 |
| Citation | Sun Y, et al. (2017) MLF1 is a proapoptotic antagonist of HOP complex-mediated survival. Biochim Biophys Acta 1864(4):719-727 |
| abstractText | In the HAX1/HtrA2-OMI/PARL (HOP) mitochondrial protein complex, anti-apoptotic signals are generated by cleavage and activation of the serine protease HtrA2/OMI by the rhomboid protease PARL upon recruitment of both proteases to inner mitochondrial membrane protein HAX1 (HS1-associated protein X-1). Here we report the negative regulation of the HOP complex by human leukemia-associated myeloid leukemia factor 1 (MLF1). We demonstrate that MLF1 physically and functionally associates with HAX1 and HtrA2. Increased interaction of MLF1 with HAX1 and HtrA2 displaces HtrA2 from the HOP complex and inhibits HtrA2 cleavage and activation, resulting in the apoptotic cell death. Conversely, over-expressed HAX1 neutralizes MLF1''s effect and inhibits MLF1-induced apoptosis. Importantly, Mlf1 deletion reverses B- and T-cell lymphopenia and significantly ameliorates the progressive striatal and cerebellar neurodegeneration observed in Hax1(-/-) mice, with a doubling of the lifespan of Mlf1(-/-)/Hax1(-/-) animals compared to Hax1(-/-) animals. Collectively, these data indicate that MLF1 serves as a proapoptotic antagonist that interacts with the HOP mitochondrial complex to modulate cell survival. |
